Wedbush Starts Durata Therapeutics (DRTX) at Outperform; Safety, Potency, Convenience Underpin Positive Outlook of Dalbavancin
Go back to Wedbush Starts Durata Therapeutics (DRTX) at Outperform; Safety, Potency, Convenience Underpin Positive Outlook of Dalbavancin| Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) | Delayed: 101.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $101.94 | 52 Week High | $101.99 | |||
| Open | $3.23 | 52 Week Low | $58.50 | |||
| Day High | $101.94 | P/E | N/A | |||
| Day Low | $101.94 | EPS | $-0.27 | |||
| Volume | 3,714 | |||||
| DURATA THERAP (NASDAQ: DRTX) | Delayed: 24.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.16 | 52 Week High | $24.33 | |||
| Open | $0.42 | 52 Week Low | $10.09 | |||
| Day High | $24.16 | P/E | 80.53 | |||
| Day Low | $24.16 | EPS | $0.30 | |||
| Volume | 765 | |||||
